NCT03022786|CompletedDMC
Improving Value of Care for Patients With Severe Stasis Dermatitis
Dermatitis
Loading search results
Dermatitis
Sponsor study identifier
interventional
28
1 country
1
Study Start
January 2017
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
October 2018
Actual (reported)Study Completion
December 2018
Actual (reported)Explore the unmet needs of patients admitted to the hospital for severely inflamed skin of the lower legs, often described as 'bilateral cellulitis". These patients usually have intractable lower extremity edema, stasis dermatitis and sometimes allergic contact dermatitis rather than an infectious process; readmission is common. Investigators will create patient and provider education materials to align dermatological, home health, and other resources and measure reduction in hospital re-admission rate and length of stay.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 29, 2016
Actual (reported)January 2017
Date type not reportedThis date has not been verified as actual or estimated.
January 16, 2017
Actual (reported)October 2018
Actual (reported)December 2018
Actual (reported)Length of stay for patients with stasis dermatitis
Feb-Sept in both years
Up to 2 years
Readmission rate for patients with stasis dermatitis
Up to 2 years
Patch testing for stasis dermatitis
Up to 2 years
Patients will be interviewed who have been diagnosed with stasis dermatitis. The Principal Investigator will learn their perspective on their leg swelling, impact on quality of life, and obstacles to wearing compression stockings
Using in-depth interviews for our inpatients selected using the same criteria as in Phase 1 and independent focus groups of providers, The study staff will obtain feedback to refine the items in our toolkit before implementing them in January 2017. There will be a focus group comprised of providers. This focus group will explore the perceptions of the providers and what unmet needs remain for the patients.
Our patient education materials and toolkit include an order set to help providers guide patients to adhere to compression, the gold standard of care for this condition. This will also direct patients to know who to contact if itching or pain persists, what the patient can do at home, when to go to the hospital, as well as information on financial and home care assistance as it relates to managing their chronic condition.
Inpatient order set and ambulatory care guide offer guidance on initial compression to decrease edema, obtaining gradient compression stockings, how to access evaluation by vascular medicine for pain or dermatology for evaluation of allergic contact dermatitis if itch persists, etc
Home Care aides trained about use of compression stockings and use of motivational interviewing as a tool to help patients make behavior changes to reduce leg swelling. This is part of our 'tool kit'. There will be a focus group comprised of providers. This focus group will explore the perceptions of the providers and what unmet needs remain for the patients.
University Hospitals
Cleveland, Ohio, 44106, United States
Susan Nedorost, MD
University Hospitals Cleveland Medical Center
28 participants (actual enrollment reported by the registry).
First Submitted
December 29, 2016
First Posted
January 16, 2017
Study Start
January 2017
Date type not reportedThis date has not been verified as actual or estimated.
Engaged physical therapists to evaluate patients for ability to don stockings, to assess need for strengthening exercises or leg exercises to improve venous return. This is part of our 'tool kit'
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
October 2018
Actual (reported)Study Completion
December 2018
Actual (reported)Last Updated
April 28, 2020
Record last verified: 2020-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: